The EEN2EIC project, EuroQuity- Bpifrance, FFG and EEN Austria are pleased to invite investors ready to invest in innovative ideas, to join the next EEN2EIC pitching session with Seal of Excellence companies from Austria, Czech Republic, Hungary and Slovenia. The onsite event will be held on Friday 01/12/2023 at Graz, Steiermärkische Sparkasse, Sparkassenplatz 4.
The pitch session will have the typical structure of 5-min pitch / 3-min Q&A with a panel of international VCs investors and the opportunity for one-on-one meetings after.
Event Details:
Event Programme:
The pitch session will have the typical structure of 5-min pitch / 3-min Q&A with a panel of international VCs investors and the opportunity for one-on-one meetings after.
Event Details:
- Date: Friday, 1st of December, 2023
- Time: 09.00 – 17.00 | doors open 08.30
- Venue: “Schlossbergsaal” of the Steiermärkische Sparkasse
- Address: Sparkassenplatz 4, 8010 Graz
Event Programme:
- 4 pitching sessions á 3-4 pitches
- Networking breaks, lunch and closing dinner (estimated end at 17.00)
- Online 1:1 follow-up meetings via b2match
AVVie GmbH – Mitral Butterfly system
Mitral valve regurgitation is defined as backflow (leaking) of blood from the left ventricle into the left atrium of the heart due to insufficient valve closure. In Europe and the US, approximately 13 million people have been diagnosed with MR. However, today, less than 5% of patients with moderate to severe disease receive treatment. AVVie has developed the Mitral Butterfly (MB) system, a novel innovative solution for patients suffering from MR and subsequent heart failure.
Employees: 20 | Serie A | Looking for Strategic support & Financing | EUR M12 sought – Austria, Vienna
AURIMOD GmbH – Unique invasive and personalized chronic pain treatment
AURIMOD is a commercial stage medical device company from Vienna, Austria. Our product VIVO offers unique minimally invasive and personalized chronic pain treatment. VIVO is a wearable neuromodulation device to be worn behind the ear utilizing auricular vagus nerve stimulation (aVNS). VIVO allows non-pharmacological treatment of chronic low back pain and migraine with a clinically proven and sustainable therapeutic effect. AURIMOD is commited to offering user centric solutions for comprehensive pain management allowing for quality of life and pain monitoring as well as therapy optimization.
Employees: 10 | pre-Serie A | Looking for Strategic support | EUR M1 sought – Austria, Vienna
UpNano GmbH – high resolution 3D printing
UpNano is a system provider for high-resolution 3D printing. In addition to the development, production and manufacturing of printing systems and the corresponding operating software, UpNano offers printing materials and accessories optimized for the process. Quality and environmental awareness are two fundamental prerequisites which are reflected in the ISO 9001 and 14001 certifications of the company.
Employees: 50 | Serie A | Looking for Strategic support & Financing | EUR M10 – M15 sought – Austria, Vienna
ReForm Therapeutics – Biopharmaceutical company targeting unmet patient needs
ReForm combines the scientific brains and research experience of a team of scientific researchers in Brno, Czech Republic with a team of international pharmaceutical executives who have 25-30 years’ experience in Business Development, Regulatory, Clinical Development and Operations Management. This combination allows us to target commercially attractive markets and niche indications for which we can conduct research and development work at one third of the cost in Western Europe.
Employees: 20| Seed | Looking for Strategic support & Financing | EUR K200 sought – Czech Republic, Brno
TERDESOL SE – Creating raw materials from waste
Terdesol SE is a start-up company founded in 2020 with the mission to take strategic advantage of the European Parliament's Directive 2018/850 on the landfill of waste, which provides for the complete closure of landfills within the next decade. The aim of our company is to establish a profitable business model by using the infrastructure of existing landfill sites. Instead of sending waste to landfill, it will be processed into various valuable raw materials and then marketed.
Employees: 50 | Serie A | Looking for Strategic support & Financing | EUR M20 sought – Czech Republic, Prague
CAPTEC Medical Ltd. – Microfluidic concept for antigen-antibody to capture cancer cells
CAPTEC Medical Kft. is a Hungary-based biotechnology SME founded by Paul Stolk (NL), Johan De Jonghe (BE), and the Hungaro-American scientist Andras Guttman. In 2013 Prof Guttman and his team developed the underlying high-throughput microfluidic concept for antigen-antibody binding process to capture cancer cells from blood. Johan, whose parents both died of cancer and Paul got to know Andras and thought of developing the technology into a treatment process that cleans the blood of cancer patients from cancer cells to improve and save their lives.
Employees: 10 | Serie A | Looking for Financing | EUR M2.5 sought – Hungary, Veszprém
ADvantage Therapeutics – Treatment of Alzheimer Disease
ADvantage Therapeutics is developing therapies to treat neurodegenerative conditions, specifically Alzheimer’s Disease (AD). We are currently preparing for phase 2b clinical trials in Europe and the US to clinically validate our lead candidate: AD04®. Our mission is to bring AD04® to the market offering the first treatment with significant disease-modifying effects for AD patients. We will achieve this by conducting rigorous research, forging strategic partnerships, and maintaining a steadfast commitment to improving patient outcomes. With AD04® and our drug development pipeline, we aim to offer innovative and effective treatments that halt the progression of AD, making a significant impact on the lives of millions of people affected by the disease and their families. Our vision is to create a world where Alzheimer's disease is a manageable condition, rather than a debilitating illness. We want to become a reference in the treatment of neurodegenerative diseases.
Employees: 20 | Serie A | Looking for Financing & Strategic support | EUR M15 sought (M8 already committed) – Austria, Vienna / US, Miami
Acies Bio – Solution for a sustainable and bio-based future
Employees: 20 | Serie A | Looking for Strategic support & Financing | EUR M12 sought – Austria, Vienna
AURIMOD GmbH – Unique invasive and personalized chronic pain treatment
AURIMOD is a commercial stage medical device company from Vienna, Austria. Our product VIVO offers unique minimally invasive and personalized chronic pain treatment. VIVO is a wearable neuromodulation device to be worn behind the ear utilizing auricular vagus nerve stimulation (aVNS). VIVO allows non-pharmacological treatment of chronic low back pain and migraine with a clinically proven and sustainable therapeutic effect. AURIMOD is commited to offering user centric solutions for comprehensive pain management allowing for quality of life and pain monitoring as well as therapy optimization.
Employees: 10 | pre-Serie A | Looking for Strategic support | EUR M1 sought – Austria, Vienna
UpNano GmbH – high resolution 3D printing
UpNano is a system provider for high-resolution 3D printing. In addition to the development, production and manufacturing of printing systems and the corresponding operating software, UpNano offers printing materials and accessories optimized for the process. Quality and environmental awareness are two fundamental prerequisites which are reflected in the ISO 9001 and 14001 certifications of the company.
Employees: 50 | Serie A | Looking for Strategic support & Financing | EUR M10 – M15 sought – Austria, Vienna
ReForm Therapeutics – Biopharmaceutical company targeting unmet patient needs
ReForm combines the scientific brains and research experience of a team of scientific researchers in Brno, Czech Republic with a team of international pharmaceutical executives who have 25-30 years’ experience in Business Development, Regulatory, Clinical Development and Operations Management. This combination allows us to target commercially attractive markets and niche indications for which we can conduct research and development work at one third of the cost in Western Europe.
Employees: 20| Seed | Looking for Strategic support & Financing | EUR K200 sought – Czech Republic, Brno
TERDESOL SE – Creating raw materials from waste
Terdesol SE is a start-up company founded in 2020 with the mission to take strategic advantage of the European Parliament's Directive 2018/850 on the landfill of waste, which provides for the complete closure of landfills within the next decade. The aim of our company is to establish a profitable business model by using the infrastructure of existing landfill sites. Instead of sending waste to landfill, it will be processed into various valuable raw materials and then marketed.
Employees: 50 | Serie A | Looking for Strategic support & Financing | EUR M20 sought – Czech Republic, Prague
CAPTEC Medical Ltd. – Microfluidic concept for antigen-antibody to capture cancer cells
CAPTEC Medical Kft. is a Hungary-based biotechnology SME founded by Paul Stolk (NL), Johan De Jonghe (BE), and the Hungaro-American scientist Andras Guttman. In 2013 Prof Guttman and his team developed the underlying high-throughput microfluidic concept for antigen-antibody binding process to capture cancer cells from blood. Johan, whose parents both died of cancer and Paul got to know Andras and thought of developing the technology into a treatment process that cleans the blood of cancer patients from cancer cells to improve and save their lives.
Employees: 10 | Serie A | Looking for Financing | EUR M2.5 sought – Hungary, Veszprém
ADvantage Therapeutics – Treatment of Alzheimer Disease
ADvantage Therapeutics is developing therapies to treat neurodegenerative conditions, specifically Alzheimer’s Disease (AD). We are currently preparing for phase 2b clinical trials in Europe and the US to clinically validate our lead candidate: AD04®. Our mission is to bring AD04® to the market offering the first treatment with significant disease-modifying effects for AD patients. We will achieve this by conducting rigorous research, forging strategic partnerships, and maintaining a steadfast commitment to improving patient outcomes. With AD04® and our drug development pipeline, we aim to offer innovative and effective treatments that halt the progression of AD, making a significant impact on the lives of millions of people affected by the disease and their families. Our vision is to create a world where Alzheimer's disease is a manageable condition, rather than a debilitating illness. We want to become a reference in the treatment of neurodegenerative diseases.
Employees: 20 | Serie A | Looking for Financing & Strategic support | EUR M15 sought (M8 already committed) – Austria, Vienna / US, Miami
Acies Bio – Solution for a sustainable and bio-based future
Acies Bio is a microbial biotech company specializing in innovative microbial technologies for a sustainable future. With expertise in natural product synthesis and a focus on the One Carbon Bio platform, which converts methanol into high-value chemicals, Acies aims to be a premier developmental partner for various industries. They provide comprehensive R&D support to international clients, including strain engineering, bioprocess development, and pilot-scale production.
Employees: >100 | Serie A | Looking for Strategic support & Financing | EUR M2.5 sought – Ljubljana, SLOVENIA
Contexflow GmbH – Computer-aided detection software for chest CT integrated directly in your PACS
contextflow is an Austrian startup that began as part of the Medical University of Vienna (MUW) and Khresmoi European research project. In addition, we are supported by the Technical University of Vienna (TU). Founded in July 2016, contextflow was awarded that same year the Most Promising Startup Austria by the BCS Search Industry. In 2017 we received the Digital Innovation Award from the Austrian Federal Ministry of Education, Science and Research. Later in 2018, we were selected as one of 19 startups out of 700+ applications to participate in the Philips HealthWorks accelerator program. In 2019 we won Best Pitch – Healthcare at the Pioneers Festival in Vienna, and the Central European Startup Awards awarded us Best Healthcare Startup Austria. Novel machine-learning based image analysis solution to help improve radiologists' daily clinical workflows.
Employees: >50 | Serie B | Looking for Financing | EUR M2.5 sought – Vienna, Austria
Contexflow GmbH – Computer-aided detection software for chest CT integrated directly in your PACS
contextflow is an Austrian startup that began as part of the Medical University of Vienna (MUW) and Khresmoi European research project. In addition, we are supported by the Technical University of Vienna (TU). Founded in July 2016, contextflow was awarded that same year the Most Promising Startup Austria by the BCS Search Industry. In 2017 we received the Digital Innovation Award from the Austrian Federal Ministry of Education, Science and Research. Later in 2018, we were selected as one of 19 startups out of 700+ applications to participate in the Philips HealthWorks accelerator program. In 2019 we won Best Pitch – Healthcare at the Pioneers Festival in Vienna, and the Central European Startup Awards awarded us Best Healthcare Startup Austria. Novel machine-learning based image analysis solution to help improve radiologists' daily clinical workflows.
Employees: >50 | Serie B | Looking for Financing | EUR M2.5 sought – Vienna, Austria
